Press area

Cafeine to prevent Alzheimer disease? The Dr Thibaud Lebouvier, neurologist at the Memory Center of the  Lille University Hospital has received a grant to conduct the CAFCA clinical trial. This clinical trial aims to measure the capacity of coffee (more precisely cafeine) to slow down/prevent the symptoms of Alzheimer disease. This project is in collaboration … Continue reading “Cafeine to prevent Alzheimer disease? CAFCA clinical trial at the Lille University Hospital”